Jiutian Chemical’s FY2025 revenue rose to RMB 107.5 million (+113%) and its net loss attributable to shareholders widened to RMB 167.0 million (+13%), according to its unaudited full-year results for the year ended 31 December 2025. Basic and diluted loss per share was RMB 8.40 cents for FY2025, and net asset value per share was RMB 22.68 cents as at 31 December 2025. For 2H2025, revenue increased to RMB 29.9 million (+870%) and net loss attributable to shareholders was RMB 102.2 million (+61%), with loss per share of RMB 5.14 cents. Cash and cash equivalents were RMB 198.0 million as at 31 December 2025, while total assets were RMB 699.3 million and total liabilities were RMB 248.3 million. Jiutian Chemical said FY2025 revenue was mainly driven by the commencement of trial production at its 100,000-ton new methylamine plant and sales in 2Q2025 and 4Q2025, alongside ongoing chemical product trading. It added that selling prices remained below production costs amid weak demand and market oversupply, and noted it has implemented cost optimisation measures, including adjusting production levels and streamlining operations. No final dividend was declared or recommended for FY2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiutian Chemical Group Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: N5GMY23JR3K4QGAN) on February 25, 2026, and is solely responsible for the information contained therein.